From WisPolitics.com/WisBusiness.com …
— State health officials have identified a “cluster” of mpox cases in southeastern Wisconsin and are urging greater prevention efforts.
The state Department of Health Services today announced five cases of mpox have been confirmed in Wisconsin so far this year, marking an uptick in disease activity compared to recent years.
After 87 cases occurred in the state in 2022 amid a global outbreak, the state’s annual total for mpox cases fell to eight in 2023, seven in 2024 and six in 2025.
Four mpox infections occurred in Wisconsin this April alone, the most seen in a single month since late 2022, according to the latest DHS figures. This increase coincides with a jump in cases at the national level, as 535 cases were confirmed across the country as of May 3.
While the agency says the risk to the public remains low, today’s announcement encourages state residents at higher risk of exposure to speak with a health care provider about vaccination against the virus. It can be spread through intimate contact as well as contaminated items exposed to bodily fluids or sores of someone with mpox.
The disease typically begins with a rash that progresses into skin lesions, while some who get the disease experience fever and chills, muscle aches and swollen lymph nodes. DHS says the rash usually appears one to three days after the fever, though not in all cases. The agency is urging those who fall ill to avoid contact with other people until they receive care.
See the release below.
— Biohealth manufacturer Abingdon Health USA plans to spend $1.8 million to expand its presence in Madison, creating 46 jobs over a three-year period, WEDC announced today.
The Wisconsin Economic Development Corp. says it’s providing up to $370,000 in performance-based state income tax credits to encourage the effort, though the company will need to meet job creation and capital investment benchmarks to claim the credits.
The project involves setting up a contract development and manufacturing operation in the state, “mirroring” its capabilities in the United Kingdom where parent company Abingdon Health plc resides. The facility will be “designed for rapid scale-up” to meet rising demand, WEDC says.
Chris Yates, president of the company’s U.S. subsidiary, says the WEDC support “serves as a welcome endorsement of our commitment and investment” in the state.
“These tax credits will support our expansion at University Research Park in Madison, including the creation of additional skilled roles as Abingdon Health USA continues to grow to meet customer demand across the United States,” he said in a statement.
See the release below.
Top Stories
– VA studying MDMA as treatment for veterans’ PTSD
– Trump will send Americans exposed to Ebola while abroad to a new facility in Kenya
– Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
– Zuckerberg’s philanthropic venture unveils AI world model for drug discovery
– KFF’s Chief Executive to Retire
– Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
Press Releases
– Dept. of Health Services: Confirms first cases of mpox in 2026, shares prevention resources
– Wisconsin Economic Development Corp.: Expanding Wisconsin’s biohealth lead
